Annual FCF
$18.93 M
+$39.17 M+193.56%
31 December 2023
Summary:
Contineum Therapeutics Class A Common Stock annual free cash flow is currently $18.93 million, with the most recent change of +$39.17 million (+193.56%) on 31 December 2023. During the last 3 years, it has risen by +$45.37 million (+171.63%). CTNM annual FCF is now at all-time high.CTNM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$6.25 M
+$2.37 M+27.47%
30 September 2024
Summary:
Contineum Therapeutics Class A Common Stock quarterly free cash flow is currently -$6.25 million, with the most recent change of +$2.37 million (+27.47%) on 30 September 2024. Over the past year, it has increased by +$4.76 million (+43.24%). CTNM quarterly FCF is now -115.38% below its all-time high of $40.64 million, reached on 01 June 2023.CTNM Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$34.00 M
-$852.00 K-2.57%
30 September 2024
Summary:
Contineum Therapeutics Class A Common Stock TTM free cash flow is currently -$34.00 million, with the most recent change of -$852.00 thousand (-2.57%) on 30 September 2024. Over the past year, it has dropped by -$52.94 million (-279.58%). CTNM TTM FCF is now -196.20% below its all-time high of $35.35 million, reached on 01 June 2023.CTNM TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTNM Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +43.2% | -279.6% |
| 3 y3 years | +171.6% | - | - |
| 5 y5 years | - | - | - |
CTNM Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +171.6% | -115.4% | +43.2% | -196.2% | at low |
| 5 y | 5 years | at high | +171.6% | -115.4% | +43.2% | -196.2% | at low |
| alltime | all time | at high | +171.6% | -115.4% | +43.2% | -196.2% | at low |
Contineum Therapeutics Class A Common Stock Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$6.25 M(-27.5%) | -$34.00 M(+2.6%) |
| June 2024 | - | -$8.62 M(+6.1%) | -$33.15 M(-305.8%) |
| Mar 2024 | - | -$8.12 M(-26.3%) | $16.11 M(-14.9%) |
| Dec 2023 | $18.93 M | -$11.01 M(+104.0%) | $18.93 M(-36.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$5.40 M(-113.3%) | $29.95 M(-15.3%) |
| June 2023 | - | $40.64 M(-867.4%) | $35.35 M(-767.4%) |
| Mar 2023 | - | -$5.30 M | -$5.30 M |
| Dec 2022 | -$20.24 M(-23.4%) | - | - |
| Dec 2021 | -$26.43 M | - | - |
FAQ
- What is Contineum Therapeutics Class A Common Stock annual free cash flow?
- What is the all time high annual FCF for Contineum Therapeutics Class A Common Stock?
- What is Contineum Therapeutics Class A Common Stock quarterly free cash flow?
- What is the all time high quarterly FCF for Contineum Therapeutics Class A Common Stock?
- What is Contineum Therapeutics Class A Common Stock quarterly FCF year-on-year change?
- What is Contineum Therapeutics Class A Common Stock TTM free cash flow?
- What is the all time high TTM FCF for Contineum Therapeutics Class A Common Stock?
- What is Contineum Therapeutics Class A Common Stock TTM FCF year-on-year change?
What is Contineum Therapeutics Class A Common Stock annual free cash flow?
The current annual FCF of CTNM is $18.93 M
What is the all time high annual FCF for Contineum Therapeutics Class A Common Stock?
Contineum Therapeutics Class A Common Stock all-time high annual free cash flow is $18.93 M
What is Contineum Therapeutics Class A Common Stock quarterly free cash flow?
The current quarterly FCF of CTNM is -$6.25 M
What is the all time high quarterly FCF for Contineum Therapeutics Class A Common Stock?
Contineum Therapeutics Class A Common Stock all-time high quarterly free cash flow is $40.64 M
What is Contineum Therapeutics Class A Common Stock quarterly FCF year-on-year change?
Over the past year, CTNM quarterly free cash flow has changed by +$4.76 M (+43.24%)
What is Contineum Therapeutics Class A Common Stock TTM free cash flow?
The current TTM FCF of CTNM is -$34.00 M
What is the all time high TTM FCF for Contineum Therapeutics Class A Common Stock?
Contineum Therapeutics Class A Common Stock all-time high TTM free cash flow is $35.35 M
What is Contineum Therapeutics Class A Common Stock TTM FCF year-on-year change?
Over the past year, CTNM TTM free cash flow has changed by -$52.94 M (-279.58%)